Classics in Cardiovascular Endocrinology: Aldosterone Action Beyond Electrolytes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases.Frontiers in endocrinology · 2021
   Article
2. Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System.World journal of surgery · 2018
   Article
3. Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.Current hypertension reports · 2017
   Review
4. Signaling Interactions in the Adrenal Cortex.Frontiers in endocrinology · 2016
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as